Keyphrases
Brain Injury
100%
Clinical Trials
14%
Early Administration
14%
Fear Memory
14%
Hippocampal Neurodegeneration
14%
Hippocampal Neurons
14%
Hippocampal Synapses
14%
Human Traumatic Brain Injury
14%
Hypoxemia
100%
Initial Dose
14%
Long-term Efficacy
14%
Long-term Functional Outcome
100%
Memory Performance
14%
Microglial Activation
28%
Minocycline
100%
Monocyte Infiltration
14%
Neuroinflammatory Response
14%
Neuronal Loss
14%
Neuropathology
14%
Neuroprotection
14%
Neuroprotective
28%
Preclinical Efficacy
14%
Preclinical Trials
14%
Primary Injury
14%
Short Course
28%
Survivors
14%
Synapse Loss
14%
Therapeutic Window
14%
Traumatic Brain Injury
100%
White Matter Myelination
14%
Medicine and Dentistry
Brain Injury
100%
Clinical Trial
14%
Experimental Traumatic Brain Injury
14%
Hypoxemia
100%
Minocycline
100%
Myelination
14%
Neurodegeneration
14%
Neuropathology
14%
Neuroprotection
14%
Neuroprotective Agent
28%
Synapse
14%
Therapeutic Window
14%
Traumatic Brain Injury
100%
Pharmacology, Toxicology and Pharmaceutical Science
Brain Injury
100%
Clinical Trial
14%
Experimental Traumatic Brain Injury
14%
Hypoxemia
100%
Minocycline
100%
Nerve Degeneration
14%
Neuroprotection
14%
Neuroprotective Agent
28%
Therapeutic Window
14%
Traumatic Brain Injury
100%
Neuroscience
Minocycline
100%
Myelinogenesis
14%
Neurodegeneration
14%
Neuroprotection
14%
Neuroprotective Agent
28%
Neurotrauma
100%
Synapse
14%
Traumatic Brain Injury
100%
Immunology and Microbiology
Myelination
100%
Synapse
100%
White Matter
100%